Calculated based on number of publications stored in Pure and citations from Scopus

Research activity per year

Personal profile

Personal profile

Dr. Abdelrahim is a gastrointestinal medical oncologist and transplant oncologist attending to patients with upper and lower GI malignancies in addition to malignancies treated by liver transplantation. He is the section chief of GI medical oncology leading GI cancer care at Houston Methodist Neal Cancer Center with focus on clinical trial Phase II/III in GI malignancies. 

Dr. Abdelrahim serves as the medical Director of Cockrell Center for Advanced Therapeutics where he is oversees Phase I program at Houston Methodist Hospital and Neal Cancer Center. He is a principal investigator on multiple clinical trials with focus on chemotherapy, targeted therapy and immunotherapy in GI malignancies.

His translational research is focused on developing new mechanism-based drugs for the treatment of gastrointestinal cancers. He has identified for the first time a new structural class of compounds that can target selective transcription factor that are now recognized as targets for the development of new anticancer drugs. The lead compound of this class reached Phase I clinical trial to treat patients with GI cancers.

Dr Abdelrahim has published more than 130 original research articles, review articles and book chapters in prestigious journals and publishing groups.  Dr. Abdelrahim is a member of the American Society of Clinical Oncology, Society for Immunotherapy of Cancer, Cholangiocarcinoma Foundation, European Society for Medical Oncology and International Liver Transplant Society. He is the site principal investigator for Southwest Oncology Cooperative Group at Houston Methodist Neal Cancer Center. He is on the editorial boards of several medical journals where he serves as Editor-in Chief of Transplant Oncology and Cancer Nursing Care section of Cancers and associate editor of Frontiers in Oncology.

Dr. Abdelrahim completed his pharmacy degree followed by PhD and graduate work in the field of pharmacology and toxicology from Texas A&M University, College Station, Texas. He obtained his medical degree from Texas A&M University, completed residency at Baylor College of Medicine, and fellowship in medical oncology at Duke University.

Research interests

  • Targeted therapy in GI cancers
  • Transplant oncology
  • Immunotherapy
  • T cell therapy 

Dr. Abdelrahim's research has pinpointed few compounds that inhibit tumor growth and angiogenesis in-part by inducing proteasome-dependent degradation of selected Sp proteins in cancer cells and tumors. The lead compound of this class (Tolfenamic acid) has reached Phase I clinical trial to treat patients with advanced and metastatic pancreatic cancer in combination with gemcitabine and radiation therapy. Dr. Abdelrahim has a patent application submitted for the new use of these compounds in GI cancers. In prior research, he was the first to find that Sp4 protein is over expressed in GI cancers including pancreatic cancer and that the role of Sp4 can be equally important as Sp1 in some type of GI cancers.

Researchers in cancer have the ultimate responsibility of taking their findings to the clinic which is described as translational research. By seeing GI cancer patients in his practice, collaborating with translational scientists in the lab and conducting and directing clinical trials, Dr. Abdelrahim hopes to continue to fuel the translational research cycle from lab to clinic and back to the lab.


Education/Academic qualification

Medicine, MD, Texas A&M Health Science Center College of Medicine

Jul 1 2008Jun 30 2012

Award Date: Aug 12 2018

Hematology, Fellow, Duke University Medical Center

Jul 1 2015Jun 30 2017

Award Date: Jun 30 2017

Internal Medicine, Residency

Jul 1 2013Jun 30 2015

Award Date: Jun 30 2015

Internal Medicine, Internship, Baylor College of Medicine

Jul 1 2012Jun 30 2013

Award Date: Jun 30 2013

PhD, Toxicology/Pharmacology, Texas A&M University

Sep 1 2000May 31 2004

Award Date: May 31 2004

Pharmacy, B Pharm, Isra University

Sep 1 1994May 31 1999

Award Date: May 31 1999

External positions

Adjunct Assistant Professor, Texas A&M University

Jul 1 2012 → …

Research Area Keywords

  • Cancer
  • Precision Medicine
  • Clinical Translation & Trials
  • Clinical Care
  • Digestive Disorders

Free-text keywords

  • Gastrointestinal cancer
  • Clinical research
  • Clinical trials
  • Translation research
  • Transplant Oncology


Dive into the research topics where Maen Abdelrahim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or